← Eichor
Study identifier: NCT07671729 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Quadriceps Tendon vs Peroneus Longus Tendon in ACL Reconstruction

Condition: Anterior Cruciate Ligament Injury · Anterior Cruciate Ligament Rupture  ·  Sponsor: Acibadem University

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 50 Years
Healthy volunteersNo

About this study

This prospective randomized clinical trial aims to compare quadriceps tendon and peroneus longus tendon autografts in anterior cruciate ligament reconstruction. Patients with anterior cruciate ligament injury undergoing primary reconstruction surgery will be randomly assigned to one of the two graft groups. Clinical examination findings, return-to-sport outcomes, ankle muscle strength, ankle-related functional scores, and gait analysis parameters will be evaluated at 6 months and 12 months postoperatively. The study aims to investigate both knee-related functional outcomes and donor site morbidity associated with graft harvesting techniques.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (1)

Acibadem Fulya Hospital, Sport Medicine CenterIstanbul, Besiktas, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07671729